Cambrex Names Tom Vadaketh EVP And CFO - Quick Facts

(RTTNews) - Cambrex Corp. (CBM), a manufacturer of small molecule Active Pharmaceutical Ingredients, announced that it has appointed Tom Vadaketh as Executive Vice President and Chief Financial Officer, effective January 20, 2017.

Greg Sargen, CFO at Cambrex, will transition to a newly-created role, Executive Vice President, Corporate Development and Strategy. In his new role, Sargen will assume responsibility for Corporate Development and Strategy and will continue to report directly to Steven M. Klosk, President and Chief Executive Officer.

Vadaketh was most recently the CFO of the Crosby Group, a private equity-owned company and a world leader in the manufacture of rigging, lifting and material handling applications. Prior to that, he spent nine years in a variety of increasingly senior financial positions at Tyco International. In his last role at Tyco, he served as Vice President, Finance, Corporate Financial Planning & Analysis and CFO of Global Products. Prior to his time at Tyco, Vadaketh spent 15 years in a variety of senior financial roles at Proctor & Gamble, where he led several corporate and site financial functions and initiatives.